- Home
- NBIX vs BAH Comparison
NBIX vs BAH Comparison
Compare NBIX & BAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- BAH
- Stock Information
- Founded
- NBIX 1992
- BAH 1914
- Country
- NBIX United States
- BAH United States
- Employees
- NBIX N/A
- BAH N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- BAH Professional Services
- Sector
- NBIX Health Care
- BAH Consumer Discretionary
- Exchange
- NBIX Nasdaq
- BAH Nasdaq
- Market Cap
- NBIX 14.4B
- BAH 12.0B
- IPO Year
- NBIX 1996
- BAH 2010
- Fundamental
- Price
- NBIX $150.87
- BAH $87.08
- Analyst Decision
- NBIX Strong Buy
- BAH Hold
- Analyst Count
- NBIX 18
- BAH 11
- Target Price
- NBIX $172.06
- BAH $119.20
- AVG Volume (30 Days)
- NBIX 1.0M
- BAH 2.7M
- Earning Date
- NBIX 10-28-2025
- BAH 10-24-2025
- Dividend Yield
- NBIX N/A
- BAH 2.52%
- EPS Growth
- NBIX 12.44
- BAH 3.12
- EPS
- NBIX 4.19
- BAH 6.54
- Revenue
- NBIX $2,682,700,000.00
- BAH $11,706,000,000.00
- Revenue This Year
- NBIX $23.68
- BAH N/A
- Revenue Next Year
- NBIX $18.02
- BAH $2.72
- P/E Ratio
- NBIX $35.78
- BAH $13.37
- Revenue Growth
- NBIX 19.61
- BAH 2.42
- 52 Week Low
- NBIX $84.23
- BAH $82.23
- 52 Week High
- NBIX $157.67
- BAH $186.59
- Technical
- Relative Strength Index (RSI)
- NBIX 59.16
- BAH 38.44
- Support Level
- NBIX $133.62
- BAH $85.03
- Resistance Level
- NBIX $157.67
- BAH $87.72
- Average True Range (ATR)
- NBIX 4.58
- BAH 3.18
- MACD
- NBIX 0.98
- BAH -0.20
- Stochastic Oscillator
- NBIX 67.98
- BAH 24.51
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.